Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: Effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA

Infection Control and Hospital Epidemiology

Volumn 26, Issue 2, 2005, Pages 127-133

  Pan, Angelo ^a,e   Carnevale, Giuseppe ^a   Catenazzi, Patrizia ^d   Colombini, Paolo ^e   Crema, Luciano ^c   Dolcetti, Lucia ^d   Ferrari, Lucio ^b   Mondello, Placido ^a   Signorini, Liana ^e   Tinelli, Carmine ^f   Roldan, Eugenia Quiros ^e   Carosi, Giampiero ^e  

^a Divisione di Malattie Infettive   (Italy)

^b Laboratorio di Microbiologia   (Italy)

^c Istituti Ospitalieri di Cremona   (Italy)

^d Direzione Sanitaria   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; METICILLIN; NEOXIDINA MANI; PSEUDOMONIC ACID;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BLOOD CULTURE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; ITALY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; PATIENT CARE; PREVALENCE; STAPHYLOCOCCUS INFECTION;

CROSS INFECTION; HOSPITAL UNITS; HOSPITALS, COMMUNITY; HUMANS; INCIDENCE; INFECTION CONTROL; ITALY; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 20144389798     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502515     Document Type: Article

References (42)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-532.
2. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2001;29:N64-N68.
3. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001;39:3727-3732.
4. Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus (MRSA) in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-55.
5. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992-June 2001. Am J Infect Control 2001;29:404-421.
6. Anonymous. Susceptibility of Staphylococcus aureus. EARSS Bulletin. Bilthoven, the Netherlands: European Antimicrobial Resistance Surveillance System; 2002:4. Available at www.earss.rivm.nl. Accessed April 6, 2004.
7. Luzzaro F, Vigano EF, Fossati D, et al. Prevalence and drug susceptibility of pathogens causing bloodstream infections in Northern Italy: a two-year study in 16 hospitals. Eur J Microbiol Infect Dis 2002;21:849-855.
8. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus MRSA bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996;23:255-259.
9. Cosgrove SE, Sakoulas G, Perencevich EN, Schuaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-sensitive Staphylococcus aureus MRSA bacteremia. Clin Infect Dis 2003;36:53-59.
10. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Stapkylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and MRSA bacteremia. Clin Infect Dis 2003;37:1453-1460.
11. Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus MRSA bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996;100:509-516.
12. Singh N, Paterson DL, Chang FY, et al. Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000;30:322-327.
13. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial MRSA bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994;13:96-102.
14. Richet H, Benbachir M, Brown DF, et al. Are there regional variations in the diagnosis, surveillance, and control of methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2003;24:334-341.
15. Pan A, Catenazzi P, Ferrari L, et al. Evaluation of the efficacy of a program to control nosocomial spread of methicillin-resistant Staphylococcus aureus [in Italian]. Infez Med 2001;9:163-169.
16. Report of a combined working party of the Hospital Infection Society and British Society of Antimicrobial Chemotherapy. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1986;7:193-201.
17. Boyce JM, Jackson MM, Pugliese G, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infect Control Hosp Epidemiol 1994;15:105-115.
18. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 1991;91:S221-S227.
19. Guiguet M, Rekacewicz C, Leclerq B, Brun Y, Escudier B, Andremont A. Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unit. Infect Control Hosp Epidemiol 1990;11:23-26.
20. Murray-Leisure KA, Geib S, Graceley D, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:343-350.
21. Pan A, Tomasoni D, Calza A, Guidelines for the control of hospital diffusion of methicillin-resistant Staphylococcus aureus. Italian Journal of Hospital Infection 1999;6:29-42.
22. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, ed. 5. Villanova, PA: National Committee for Clinical Laboratory Standards; 2000. Approved standard M7-A5.
23. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
24. Pearson ML. Guideline for prevention of intravascular device-related infections: Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:438-473.
25. Mermel LA, Farr BM, Sheretz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-1272.
26. Clark DE, Cushing BM, Bredenberg CE. Monitoring hospital trauma mortality using statistical process control methods. J Am Coll Surg 1998;186:630-635.
27. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309-317.
28. Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:43-49.
29. Harbarth S, Pittet D. Control of nosocomial methicillin-resistant Staphylococcus aureus: where shall we send our hospital director next time? Infect Control Hosp Epidemiol 2003;24:314-316
30. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus MRSA bacteremia. N Engl J Med 2001;344:11-16.
31. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346:1871-1877.
32. Vrien MR, Fluit AC, Foelstra, A, Verhoef J, Van Der Werken C. Are methicillin-resistant Staphylococcus aureus more contagious than methicillin sensitive Staphylococcus aureus in a surgical intensive care unit? Infect Control Hosp Epidemiol 2002;23:491-494.
33. Muto C, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-386.
34. Roghmann MC, Siddiqui A, Plaisance K, Standiford H. MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. J Hosp Infect 2001;47:98-103.
35. Squier C, Rihs JD, Risa KJ, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 2002;23:495-501.
36. Harbarth S, Dharan S, Lassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43:1412-1416.
37. Vandenbroucke-Grauls CM. Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol 1996;17:512-513.
38. Vandenberghe A, Laterre P-F, Goenen M, et al. Surveillance of hospital acquired infections in an intensive care department: the benefit of the full time presence of an infection control nurse. J Hosp Infect 2002;52:56-59.
39. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003;9:1179-1186.
40. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary MRSA bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408-411.
41. Stone PW, Larson E, Kamar LN. A systematic audit on economic evidence linking nosocomial infections and infection control intervention: 1999-2000. Am J Infect Control 2002;30:145-152.
42. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002;23:190-197.